Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:0874)

Market Cap	35.09B -19.7%
Revenue (ttm)	89.95B +2.8%
Net Income	2.96B -8.5%
EPS	1.82 -8.6%
Shares Out	n/a
PE Ratio	11.86
Forward PE	12.09
Dividend	0.86 (6.51%)
Ex-Dividend Date	Sep 3, 2026

Volume	530,100
Open	13.20
Previous Close	13.20
Day's Range	13.08 - 13.22
52-Week Range	13.08 - 20.40
Beta	0.17
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About HKG:0874

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People’s Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, development, manufacturing, and sale of chemical drugs, chemical raw materials, and chemical raw material intermediates; and research, development, productio...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1997
• Employees: 26,365
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0874

Financial Performance

In 2025, HKG:0874's revenue was 77.66 billion, an increase of 3.55% compared to the previous year's 74.99 billion. Earnings were 2.98 billion, an increase of 5.21%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 16, 2026

Data Sources Report a data error